LTRN

Lantern Pharma Inc.

Healthcare · Biotechnology

$136.77 sample

-1.70 (-1.23%) 1D

Market cap

$345.9B

Price as of

2026-10-03

Latest filing

8-K · 2026-08-10

Alerts

8

Price$136.77 +9.48% 3M daily closessample

138.47114.15

2026-07-072026-07-292026-08-202026-09-102026-10-02

purchase / approvalsale / rejectionfiling / neutral

Latest events

Filings, trades, FDA; newest first

Sep 28INSInsider sell: 10% owner
Sep 21INSInsider buy: Chief Executive Officer
Sep 14INSInsider sell: Chief Executive Officer
Sep 07INSInsider sell: Director
Aug 27INSInsider buy: Director
Aug 20INSInsider buy: Chief Executive Officer
Aug 13INSInsider sell: EVP, Operations
Aug 10SEC10-Q filed

Sign up to see the real LTRN record →

Company facts

SEC EDGAR registration

Name: Lantern Pharma Inc.
Sector: Healthcare
Industry: Biotechnology
Smart-money score: +41sample, -100 to +100
Reporting currency: USD

Who is positioning in LTRN

sample

Insiders: 6 insider transactions over 90 days, net selling, $627.8M
Congress: 1 members traded over 90 days
Institutions · 13F: 9 funds hold $6.2B
Activists · 13D/G: No 13D/13G activist filings on record

How are the fundamentals trending?

sample, by period end

Revenue$22.9B +20.5% y/y

Q4 2024Q3 2026

Inventory$13.7B +14.5% y/y

Q4 2024Q3 2026

Accounts receivable$9.7B +15.2% y/y

Q4 2024Q3 2026

Total debt$26.3B +8.0% y/y

Q4 2024Q3 2026

Peers

sample

Sample peer A: $91.4B -6.8% 3M
Sample peer B: $230.7B -1.3% 3M
Sample peer C: $339.2B +12.0% 3M
Sample peer D: $277.9B -13.0% 3M
Sample peer E: $141.2B +3.3% 3M